Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Public Health

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2105/AJPH.2011.300283PMID 22095341PMCID PMC3490570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions to improve antibiotic prescribing practices for hospital inpatients.

  2017cited by this paper
• Availability of cefixime 400 mg tablets--United States, April 2008.

  2008cited by this paper
• Emerging Antimicrobial Resistance in Neisseria gonorrhoeae: Urgent Need to Strengthen Prevention Strategies

  2008cited by this paper
• Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

  2007cited by this paper
• Update on the management of gonorrhea in adults in the United States.

  2007cited by this paper
• Antimicrobial Resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: The Spread of Fluoroquinolone Resistance

  2007cited by this paper
• Estimating dissemination of Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines from a survey of physicians

  2007cited by this paper
• Interventions to improve antibiotic prescribing practices in ambulatory care.

  2005cited by this paper
• Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

  2004cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.

  2004cited by this paper
• Antimicrobial Prescribing in the United States: Good News, Bad News

  2003cited by this paper
• Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

  2002cited by this paper
• Combating antimicrobial resistance: Intervention programs to promote appropriate antibiotic use

  2002cited by this paper
• Comparing Quality of Care for Sexually Transmitted Diseases in Specialized and General Clinics

  2002cited by this paper
• Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.

  2000cited by this paper
• From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

  1999cited by this paper
• Mandatory reporting of diseases and conditions by health care professionals and laboratories.

  1999cited by this paper
• Forecasting with Dynamic Regression Models: Pankratz/Forecasting

  1991cited by this paper
• On a measure of lack of fit in time series models

  1978cited by this paper

• Bayesian hierarchical models incorporating measurement error for interrupted time series design

  2023cites this paper
• Chemosensor for Colorimetric Detection of Fluoroquinolone Antibiotics

  2023cites this paper
• Effect of Antimicrobial Stewardship on Reduced Oral Antibiotic Use and Bacterial Resistance at an Outpatient Department in a Medium-Sized Hospital -Achievement of the Target Values of the National Action Plan on Antimicrobial Resistance in Japan-

  2021cites this paper
• Methods, Applications and Challenges in the Analysis of Interrupted Time Series Data: A Scoping Review

  2020cites this paper
• Gonorrhea: Historical outlook

  2020cites this paper
• Gonorrhea Screening Among U.S.-bound Immigrants and Refugees, 2018

  2019cites this paper
• Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

  2019cites this paper
• Improved Methods for Interrupted Time Series Analysis Useful When Outcomes are Aggregated: Accounting for heterogeneity across patients and healthcare settings

  2019cites this paper
• A review on recent development on fluoroquinolones

  2019cites this paper
• Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea — STD Surveillance Network, United States, 2016

  2018cites this paper
• Gonorrhea

  2017cites this paper
• The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis

  2017cites this paper
• Antimicrobial Drug Resistance

  2017influential citation
• Treatment of gonorrhoea in Auckland, New Zealand: marked variation in prescriber adherence to treatment guidelines

  2017cites this paper
• Verifying Treatment of Reported Cases of Gonorrhea

  2016cites this paper
• Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

  2016cites this paper
• Time Series Modelling of Syphilis Incidence in China from 2005 to 2012

  2016cites this paper
• Temporal and long-term trend analysis of class C notifiable diseases in China from 2009 to 2014

  2016cites this paper
• The Management of Gonococcal Infections and the Development and Use of Treatment Guidelines

  2016cites this paper
• Gonorrhea Treatment Practices in the STD Surveillance Network, 2010–2012

  2015cites this paper
• Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations.

  2015cites this paper
• Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011–2012

  2015influential citation
• Management of Pelvic Inflammatory Disease in Selected US Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010–December 2011

  2015cites this paper
• Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000-2010.

  2015cites this paper
• Antimicrobial Stewardship in Outpatient Settings: A Systematic Review

  2014cites this paper
• Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes.

  2014cites this paper
• Variation in Adherence to the Treatment Guidelines for Neisseria gonorrhoeae by Clinical Practice Setting, California, 2009 to 2011

  2014cites this paper
• Provider characteristics associated with guideline-nonadherent gonorrhea treatment, Massachusetts, 2010.

  2014cites this paper
• Prostate cancer screening and incidence: a question of causality--reply.

  2013cites this paper
• Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006–June 2012

  2013cites this paper
• Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005–2010

  2013cites this paper
• The use of cephalosporins for gonorrhea: an update on the rising problem of resistance

  2012cites this paper